Concepedia

Drug-device Compatibility

Drug-Device Compatibility is a technical and regulatory construct that ensures the functional and physicochemical interoperability between a pharmaceutical product and its associated delivery device, such that the device maintains the drug’s stability, delivers the correct dosage, and performs reliably under defined conditions.

6

Publications

187

Citations

36

Authors

21

Institutions

Publications per year

2017–2026

3

Parents

Publications

6

Product–service systems in health care: case study of a drug–device combination

Stephan Mittermeyer, James Njuguna, J.R. Alcock · The International Journal of Advanced Manufacturing Technology · 2010 · 53 citations

, , +16

Drug‐Device Interactions: Clinical Considerations

James A. Reiffel, James Coromilas, John M. Zimmerman et al. · Pacing and Clinical Electrophysiology · 1985 · 49 citations

, , +11

An Industry Perspective on Compatibility Assessment of Closed System Drug-Transfer Devices for Biologics

Ahmed Besheer, Lori Burton, Richard J. Galas et al. · Journal of Pharmaceutical Sciences · 2020 · 32 citations · Full text

, , +12

Tertiary patenting on drug–device combination products in the United States

Reed F. Beall, Aaron S. Kesselheim · Nature Biotechnology · 2018 · 23 citations

, , +14

A Systematic Approach to Evaluating Closed System Drug-Transfer Devices During Drug Product Development

Sanket Patke, Erika Naumann Gaillat, Cesar Calero‐Rubio et al. · Journal of Pharmaceutical Sciences · 2021 · 19 citations

, , +16

1–5 of 6

Authors

36

  1. AB
    Ahmed Besheer

    Ludwig-Maximilians-Universität München, Germany

    1 publications · 32 citations

    1

    h-index

  2. SN
    Shubhadra N. Singh

    GlaxoSmithKline (United States), United States

    1 publications · 32 citations

    1

    h-index

  3. CN
    Chakravarthy Narasimhan

    Merck & Co., Inc., Rahway, NJ, USA (United States), United States

    1 publications · 32 citations

    1

    h-index

  4. JN
    James Njuguna

    Robert Gordon University, United Kingdom

    1 publications · 53 citations

    1

    h-index

  5. ES
    Elaine S. E. Stokes

    AstraZeneca (United Kingdom), United Kingdom

    1 publications · 32 citations

    1

    h-index

1–5 of 36

Institutions

21

  1. Merck & Co., Inc., Rahway, NJ, USA (United States)

    Rahway, United States

    1 h-index

    1 publications

    32 citations

  2. Columbia University

    New York, United States

    1 h-index

    4 publications

    196 citations

  3. Pfizer (United States)

    New York, United States

    1 h-index

    1 publications

    32 citations

  4. Brainlab (Germany)

    Munich, Germany

    1 h-index

    1 publications

    53 citations

  5. Takeda (United States)

    Deerfield, United States

    1 h-index

    2 publications

    64 citations

  6. Cranfield University

    Cranfield, United Kingdom

    1 h-index

    2 publications

    106 citations

  7. Janssen (United States)

    Hopewell, United States

    1 h-index

    3 publications

    96 citations

  8. Sanofi (France)

    Paris, France

    1 h-index

    8 publications

    152 citations

1–8 of 21

Venues

  1. Journal of Pharmaceutical Sciences

    2 publications · 51 citations

    2

    h-index

  2. Nature Biotechnology

    1 publications · 23 citations

    1

    h-index

  3. 1

    h-index

  4. Therapeutic Innovation & Regulatory Science

    TIRS · 1 publications · 11 citations

    1

    h-index

  5. Pacing and Clinical Electrophysiology

    PACE · 1 publications · 49 citations

    1

    h-index

1–5